CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO sold 4,122 shares at $21.38 ($88,108)
- 4 Open-market sale Patel Kinnari sold 1,330 shares at $21.38 ($28,429)
- 4 Open-market sale Militello John sold 245 shares at $21.38 ($5,237)
- 4 Exercise or conversion CEO acquired 7,979 shares (option exercise)
- 4 Exercise or conversion Militello John acquired 725 shares (option exercise)
- 4 Exercise or conversion Patel Kinnari acquired 3,989 shares (option exercise)
- 4 Open-market sale Militello John sold 2,342 shares at $18.65 ($43,678)
- 4 Exercise or conversion Militello John acquired 6,364 shares (option exercise)
- 4 Grant or award Chief Medical Officer acquired 76,662 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition 10% owner acquired 529,038 shares (other)
- 4 Open-market sale Schwartz Jonathan David sold 3,557 shares at $19.06 ($67,796)
- 4 Open-market sale Militello John sold 1,244 shares at $19.06 ($23,711)
Page 10 of 21 · 408 filings